glp 1 mechanism of action diagram GLP1-GIP receptor co-agonists: a promising evolution in the treatment type 2 diabetes | Acta Diabetologica Frontiers | GLP-1 Receptor Agonists:

For example, Exanatide alone, or in combination with insulin therapy or immunosuppressants, such as daclizumab, but did not improve C-peptide secretion (Rother et al, 2009)

Help us fund more projects in 2026

Temporary dose reduction often allows symptom resolution while maintaining therapeutic benefit

Increasing injection frequency beyond the recommended schedule is not supported by clinical evidence and could potentially increase the risk of adverse effects without additional weight loss benefits

While prednisone offers significant therapeutic benefits, it requires careful monitoring and dosing from your healthcare provider due to possible side effects, particularly with long term treatment